Detection/NN
of/IN
intracellular/JJ
phosphorylated/VBN
STAT-1/NN
by/IN
flow/NN
cytometry/NN
./.

We/PRP
have/VBP
applied/VBN
flow/NN
cytometry/NN
to/TO
the/DT
investigation/NN
of/IN
interferon-gamma/NN
activation/NN
of/IN
human/JJ
monocytes/NNS
./.
=====
This/DT
approach/NN
uses/VBZ
monoclonal/JJ
antibodies/NNS
that/WDT
distinguish/VBP
between/IN
the/DT
native/JJ
and/CC
phosphorylated/JJ
forms/NNS
of/IN
STAT-1/NN
./.
=====
It/PRP
enables/VBZ
rapid/JJ
and/CC
quantitative/JJ
assessment/NN
of/IN
STAT-1/NN
phosphorylation/NN
on/IN
a/DT
discrete/JJ
cell/NN
basis/NN
and/CC
is/VBZ
both/CC
more/RBR
sensitive/JJ
and/CC
less/JJR
time/NN
consuming/JJ
than/IN
immunoblotting/NN
./.
=====
Furthermore/RB
,/,
it/PRP
allows/VBZ
for/IN
discrimination/NN
between/IN
a/DT
mixture/NN
of/IN
cells/NNS
that/WDT
differ/VBP
in/IN
their/PRP$
response/NN
to/TO
interferon-gamma/NN
./.
=====
This/DT
approach/NN
should/MD
allow/VB
for/IN
the/DT
evaluation/NN
of/IN
different/JJ
intracellular/JJ
signaling/NN
pathways/NNS
using/VBG
a/DT
combination/NN
of/IN
monoclonal/JJ
reagents/NNS
that/WDT
are/VBP
specific/JJ
for/IN
native/JJ
and/CC
activation/NN
modified/JJ
proteins/NNS
./.
=====
Application/NN
of/IN
this/DT
form/NN
of/IN
testing/NN
should/MD
prove/VB
valuable/JJ
in/IN
screening/VBG
for/IN
signaling/VBG
defects/NNS
in/IN
selected/VBN
patients/NNS
with/IN
recurrent/JJ
infections/NNS
./.
=====
In/IN
addition/NN
,/,
this/DT
technique/NN
should/MD
permit/VB
dissection/NN
of/IN
a/DT
full/JJ
range/NN
of/IN
cellular/JJ
signaling/NN
pathways/NNS
at/IN
the/DT
protein/NN
level/NN
./.